| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.002 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |